Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells.
Mitsuyasu RT; Merigan TC; Carr A; Zack JA; Winters MA; Workman C; Bloch M; Lalezari J; Becker S; Thornton L; Akil B; Khanlou H; Finlayson R; McFarlane R; Smith DE; Garsia R; Ma D; Law M; Murray JM; von Kalle C; Ely JA; Patino SM; Knop AE; Wong P; Todd AV; Haughton M; Fuery C; Macpherson JL; Symonds GP; Evans LA; Pond SM; Cooper DA; Nature Medicine, 2009, vol. 15, issue 3, p 285, ISSN 1546170x. ISBN 1546170x.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef